prostate cancer, novel intrinsic subtypes, study, ASTRO 2016
News | Prostate Cancer | September 26, 2016

In the largest study of its kind to date, researchers have identified and validated three distinct molecular...

Mevion, RaySearch, ASTRO 2016, collaboration, RayCare OIS, S250i, Hyperscan, Adaptive Aperture
News | Radiation Therapy | September 26, 2016

RaySearch and Mevion Medical Systems are extending their collaboration agreement to support the RayCare oncology...

News | Lung Cancer | September 26, 2016

September 26, 2016 — A new analysis of Veteran’s Affairs Central Cancer Registry records demonstrates a clear...

IBA, Philips, adaptive proton therapy planning, ASTRO 2016, collaboration
News | Proton Therapy | September 26, 2016

September 26, 2016 — IBA (Ion Beam Applications S.A.) and Philips announced that they are stepping up their combined...

prostate cancer, hypofractionated radiation therapy, HYPO-RT-PC trial, ASTRO 2016
News | Prostate Cancer | September 26, 2016

September 26, 2016 — For men with intermediate-risk...

brain metastases, stereotactic radiosurgery, SRS, local recurrence, ASTRO 2016 study
News | Radiation Therapy | September 26, 2016

Stereotactic radiosurgery (SRS) for brain metastases decreases the likelihood of local recurrence but shows no...

Elekta, ASTRO 2016, HD Dynamic Radiosurgery, brachytherapy
News | Radiation Therapy | September 26, 2016

September 26, 2016 — At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept.

hypofractionated radiation therapy, NSCLC patients, non-small cell lung cancer, ASTRO 2016
News | Lung Cancer | September 26, 2016

New research suggests hypofractionated radiation therapy (RT) offers similar results to standard RT in several key...

News | Proton Therapy | September 23, 2016

September 23, 2016 — IBA unveiled its new platform, 'Leading the PATh', which gathers the leading experts in the...

ZDi Solutions, Z-System, radiation therapy, proton therapy, patient positioning, ASTRO 2016
News | Patient Positioning Radiation Therapy | September 23, 2016

ZDi Solutions LLC announced that it will soon market its Z-System patient positioning devices to proton therapy and...

ASTRO, ASCO, SSO, guideline update, post-mastectomy radiotherapy, PMRT, radiation therapy
News | Radiation Therapy | September 23, 2016

September 23, 2016 — Three leading national cancer organizations issued a joint clinical practice guideline update...

Mevion S250i, Hyperscan pencil beam scanning, the Netherlands, proton therapy, IMPT, ZON-PTC
News | Proton Therapy | September 23, 2016

Mevion Medical Systems announced that it will be installing its Mevion S250i proton therapy system at the Zuidoost...

Vision RT, AlignRT, clinical data, radiation therapy, ASTRO 2016
News | Patient Positioning Radiation Therapy | September 23, 2016

Vision RT announced it will be exhibiting at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting...

News | Radiation Therapy | September 22, 2016

At the 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston, Siemens...

Mevion, Hyperscan with Adaptive Aperture, intensity modualted proton therapy, IMPT, ASTRO 2016
News | Radiation Therapy | September 22, 2016

Mevion Medical Systems will showcase its pencil beam scanning Hyperscan with Adaptive Aperture at the 2016 American...

Fujifilm, Synapse VNA, oncology facilities milestone, ASTRO 2016, radiation oncology
News | Vendor Neutral Archive (VNA) | September 22, 2016

The TeraMedica Division of Fujifilm Medical Systems U.S.A. Inc. recently announced a significant business milestone...

Neiman Health Policy Institute study, Medicare Shared Savings Program, MSSP, participation, alternative payment models, APM
News | Business | September 22, 2016

September 20, 2016 — A new study by the Harvey L.

GE Healthcare, Vivid iq portable cardiovascular ultrasound, RSNA 2016, launch
Technology | Cardiovascular Ultrasound | September 22, 2016

GE Healthcare announced the global commercial launch of its new generation of high-end portable compact...

Photo courtesy of Philips Healthcare

Blog | Information Technology | September 22, 2016

Already last century (it feels strange writing that) someone, somewhere realized that laptops had enough horsepower...

PET probes, breast cancer, surface receptor changes, MGH study, Memorial Sloan Kettering

After molecularly targeted therapy with an AKT inhibitor, the receptor tyrosine kinase (RTK) HER3 increases in this particular tumor, but the RTK EGFR does not. In this example, starting HER3 inhibitor therapy in addition to AKT inhibitor therapy is likely to be beneficial, but the addition of EGFR inhibitor therapy is not likely to be beneficial for treating this tumor. Image courtesy of Massachusetts General Hospital, Boston.

News | Nuclear Imaging | September 20, 2016

September 20, 2016 — Cancer biologists know that inhibitor-mediated feedback loop changes (increased expression of a...

Overlay Init